1 ml vial tirzepatide Injection | Starts at $249/mo 1 and GIP therapy Tirzepatide Dosage Chart & Dosing

The two drugs produce overlapping but non-identical effects through different pathways

CJC 1295 provides several metabolic and wellness benefits, including increased muscle mass, reduced body fat, and improved recovery from physical exertion

We're not a chain

This correlation value was usually not reported in the studies

UHCs typical prior authorization requirements for Wegovy and Zepbound include: BMI documentation A documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea Comorbidity evidence Clinical records documenting the specific comorbidities that support the medical necessity of treatment Supervised weight management history Evidence of participation in a structured weight management program, which may include diet, exercise, and behavioral counseling, typically for 3 to 6 months prior to the request Prescriber qualifications The prescriber must be a physician, nurse practitioner, or physician assistant with appropriate prescribing authority UHC reviews prior authorizations against specific clinical policy bulletins